Global West Nile Virus Infections Medicine Market
Market Status, Strategic Analysis & Forecast (2026–2036)
Market Overview
West Nile Virus (WNV) infection is a mosquito-borne viral disease that can lead to neurological complications such as encephalitis, meningitis, and acute flaccid paralysis in severe cases. Currently, there is no widely approved, virus-specific curative therapy, and treatment is largely supportive. However, increasing disease incidence, climate-driven vector expansion, and rising neurological case reporting are accelerating R&D investments in antiviral agents, immunotherapies, and biologics.
The global West Nile Virus Infections Medicine market was valued at USD XX million in 2020 and is projected to reach USD XX million by 2036, expanding at a CAGR of XX% during 2026–2036. Growth is driven primarily by unmet medical need, expanding surveillance programs, and increased funding for emerging infectious disease therapeutics.
Segments Analysis
By Product Type
-
AGS-v
-
BG-323
-
CEL-1000
-
FDX-000
-
Others
By Drug Class (Expanded Segmentation)
-
Antiviral Agents
-
Immunomodulators
-
Monoclonal Antibodies
-
Interferon-Based Therapies
-
Supportive & Adjunctive Therapies
By Route of Administration (New)
-
Intravenous
-
Oral
-
Parenteral
By Application
-
Hospital
-
Clinic
-
Others
By Patient Type (Added)
-
Pediatric
-
Adult
-
Geriatric
Key Market Players
Core Manufacturers
-
CEL-SCI Corp
-
Fab’entech SA
-
Hemispherx Biopharma Inc
-
Kineta Inc
-
Nanotherapeutics Inc
-
Plex Pharmaceuticals Inc
-
Theravectys SA
Additional & Emerging Players (Expanded)
-
Vaxart Inc
-
GeoVax Labs
-
Emergent BioSolutions
-
Bavarian Nordic
-
Avidity Biosciences
Regional Analysis
North America
-
Highest reported incidence of WNV neurological cases
-
Strong public health surveillance infrastructure
-
Significant government and biodefense funding
Europe
-
Sporadic outbreaks with increasing southern and eastern spread
-
Growing research collaboration and clinical trial activity
Asia-Pacific
-
Rising vector presence due to climate change
-
Underdiagnosis but increasing awareness and screening programs
Central & South America
-
Expanding mosquito habitats
-
Limited treatment access but growing public health focus
Middle East & Africa
-
Endemic vector presence
-
Market growth constrained by healthcare infrastructure variability
Porter’s Five Forces Analysis
| Force | Impact |
|---|---|
| Threat of New Entrants | Medium |
| Bargaining Power of Suppliers | Low |
| Bargaining Power of Buyers | High (public health systems) |
| Threat of Substitutes | Low |
| Competitive Rivalry | Medium |
SWOT Analysis
Strengths
-
High unmet clinical need
-
Strong government and institutional funding
-
Growing neurological disease awareness
Weaknesses
-
Limited approved therapies
-
Small patient pool compared to chronic diseases
-
Long clinical development timelines
Opportunities
-
Development of first-in-class targeted therapies
-
Expansion of antiviral platforms to other flaviviruses
-
Emergency-use and orphan drug designations
Threats
-
Unpredictable outbreak patterns
-
High R&D costs with uncertain returns
-
Regulatory and ethical challenges in clinical trials
Trend Analysis
-
Increasing focus on immunotherapy and monoclonal antibodies
-
Rising collaboration between biotech firms and government agencies
-
Use of platform-based antiviral technologies
-
Integration of WNV drug development into broader pandemic preparedness strategies
Market Drivers
-
Rising incidence of mosquito-borne diseases
-
Climate change increasing vector distribution
-
Increased neurological complication reporting
-
Public health preparedness and biodefense initiatives
Market Challenges
-
Lack of standardized treatment protocols
-
Difficulty in conducting large-scale clinical trials
-
Limited commercial incentives due to episodic outbreaks
Value Chain Analysis
-
Disease Surveillance & Epidemiological Research
-
Drug Discovery & Preclinical Development
-
Clinical Trials & Regulatory Review
-
Manufacturing & Quality Control
-
Public Health Procurement
-
Hospital & Clinical Administration
Quick Recommendations for Stakeholders
-
Pharmaceutical Companies: Prioritize platform technologies adaptable to multiple flaviviruses
-
Investors: Focus on companies with orphan-drug or biodefense funding support
-
Governments & Agencies: Expand funding for late-stage clinical trials
-
Hospitals: Strengthen diagnostic and early-intervention capabilities
-
Researchers: Pursue combination therapies targeting immune response modulation
Conclusion
The West Nile Virus Infections Medicine Market remains a high-unmet-need, innovation-driven segment within the global infectious disease therapeutics landscape. Although commercially niche, its strategic importance in public health, biodefense, and emerging disease preparedness positions it for steady long-term growth. Continued R&D investment and regulatory support are expected to shape the market through 2036 and beyond.
Table of Contents
Global West Nile Virus Infections Medicine Market Research Report 2026
1 Industry Overview of West Nile Virus Infections Medicine
1.1 Definition and Specifications of West Nile Virus Infections Medicine
1.1.1 Definition of West Nile Virus Infections Medicine
1.1.2 Specifications of West Nile Virus Infections Medicine
1.2 Classification of West Nile Virus Infections Medicine
1.2.1 AGS-v
1.2.2 BG-323
1.2.3 CEL-1000
1.2.4 FDX-000
1.2.5 Others
1.3 Applications of West Nile Virus Infections Medicine
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of West Nile Virus Infections Medicine
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of West Nile Virus Infections Medicine
2.3 Manufacturing Process Analysis of West Nile Virus Infections Medicine
2.4 Industry Chain Structure of West Nile Virus Infections Medicine
3 Technical Data and Manufacturing Plants Analysis of West Nile Virus Infections Medicine
3.1 Capacity and Commercial Production Date of Global West Nile Virus Infections Medicine Major Manufacturers
3.2 Manufacturing Plants Distribution of Global West Nile Virus Infections Medicine Major Manufacturers
3.3 R&D Status and Technology Source of Global West Nile Virus Infections Medicine Major Manufacturers
3.4 Raw Materials Sources Analysis of Global West Nile Virus Infections Medicine Major Manufacturers
4 Global West Nile Virus Infections Medicine Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global West Nile Virus Infections Medicine Capacity and Growth Rate Analysis
4.2.2 West Nile Virus Infections Medicine Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global West Nile Virus Infections Medicine Sales and Growth Rate Analysis
4.3.2 West Nile Virus Infections Medicine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global West Nile Virus Infections Medicine Sales Price
4.4.2 West Nile Virus Infections Medicine Sales Price Analysis (Company Segment)
5 West Nile Virus Infections Medicine Regional Market Analysis
5.1 North America West Nile Virus Infections Medicine Market Analysis
5.1.1 North America West Nile Virus Infections Medicine Market Overview
5.1.2 North America E West Nile Virus Infections Medicine Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E West Nile Virus Infections Medicine Sales Price Analysis
5.1.4 North America West Nile Virus Infections Medicine Market Share Analysis
5.2 Europe West Nile Virus Infections Medicine Market Analysis
5.2.1 Europe West Nile Virus Infections Medicine Market Overview
5.2.2 Europe E West Nile Virus Infections Medicine Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E West Nile Virus Infections Medicine Sales Price Analysis
5.2.4 Europe West Nile Virus Infections Medicine Market Share Analysis
5.3 China West Nile Virus Infections Medicine Market Analysis
5.3.1 China West Nile Virus Infections Medicine Market Overview
5.3.2 China E West Nile Virus Infections Medicine Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E West Nile Virus Infections Medicine Sales Price Analysis
5.3.4 China West Nile Virus Infections Medicine Market Share Analysis
5.4 Japan West Nile Virus Infections Medicine Market Analysis
5.4.1 Japan West Nile Virus Infections Medicine Market Overview
5.4.2 Japan E West Nile Virus Infections Medicine Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E West Nile Virus Infections Medicine Sales Price Analysis
5.4.4 Japan West Nile Virus Infections Medicine Market Share Analysis
5.5 Southeast Asia West Nile Virus Infections Medicine Market Analysis
5.5.1 Southeast Asia West Nile Virus Infections Medicine Market Overview
5.5.2 Southeast Asia E West Nile Virus Infections Medicine Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E West Nile Virus Infections Medicine Sales Price Analysis
5.5.4 Southeast Asia West Nile Virus Infections Medicine Market Share Analysis
5.6 India West Nile Virus Infections Medicine Market Analysis
5.6.1 India West Nile Virus Infections Medicine Market Overview
5.6.2 India E West Nile Virus Infections Medicine Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E West Nile Virus Infections Medicine Sales Price Analysis
5.6.4 India West Nile Virus Infections Medicine Market Share Analysis
6 Global E West Nile Virus Infections Medicine Segment Market Analysis (by Type)
6.1 Global E West Nile Virus Infections Medicine Sales by Type
6.2 Different Types of West Nile Virus Infections Medicine Product Interview Price Analysis
6.3 Different Types of West Nile Virus Infections Medicine Product Driving Factors Analysis
6.3.1 AGS-v Growth Driving Factor Analysis
6.3.2 BG-323 Growth Driving Factor Analysis
6.3.3 CEL-1000 Growth Driving Factor Analysis
6.3.4 FDX-000 Growth Driving Factor Analysis
6.3.5 Others Growth Driving Factor Analysis
7 Global E West Nile Virus Infections Medicine Segment Market Analysis (by Application)
7.1 Global E West Nile Virus Infections Medicine Consumption by Application
7.2 Different Application of West Nile Virus Infections Medicine Product Interview Price Analysis
7.3 Different Application of West Nile Virus Infections Medicine Product Driving Factors Analysis
7.3.1 Hospital of West Nile Virus Infections Medicine Growth Driving Factor Analysis
7.3.2 Clinic of West Nile Virus Infections Medicine Growth Driving Factor Analysis
7.3.3 Others of West Nile Virus Infections Medicine Growth Driving Factor Analysis
8 Major Manufacturers Analysis of West Nile Virus Infections Medicine
8.1 CEL-SCI Corp
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 CEL-SCI Corp West Nile Virus Infections Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 CEL-SCI Corp West Nile Virus Infections Medicine Business Region Distribution Analysis
8.2 Fab'entech SA
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Fab'entech SA West Nile Virus Infections Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Fab'entech SA West Nile Virus Infections Medicine Business Region Distribution Analysis
8.3 Hemispherx Biopharma Inc
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Hemispherx Biopharma Inc West Nile Virus Infections Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Hemispherx Biopharma Inc West Nile Virus Infections Medicine Business Region Distribution Analysis
8.4 Kineta Inc
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Kineta Inc West Nile Virus Infections Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Kineta Inc West Nile Virus Infections Medicine Business Region Distribution Analysis
8.5 Nanotherapeutics Inc
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Nanotherapeutics Inc West Nile Virus Infections Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Nanotherapeutics Inc West Nile Virus Infections Medicine Business Region Distribution Analysis
8.6 Plex Pharmaceuticals Inc
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Plex Pharmaceuticals Inc West Nile Virus Infections Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Plex Pharmaceuticals Inc West Nile Virus Infections Medicine Business Region Distribution Analysis
8.7 Theravectys SA
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Theravectys SA West Nile Virus Infections Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Theravectys SA West Nile Virus Infections Medicine Business Region Distribution Analysis
9 Development Trend of Analysis of West Nile Virus Infections Medicine Market
9.1 Global West Nile Virus Infections Medicine Market Trend Analysis
9.1.1 Global 2018-2025 West Nile Virus Infections Medicine Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 West Nile Virus Infections Medicine Sales Price Forecast
9.2 West Nile Virus Infections Medicine Regional Market Trend
9.2.1 North America 2018-2025 West Nile Virus Infections Medicine Consumption Forecast
9.2.2 Europe 2018-2025 West Nile Virus Infections Medicine Consumption Forecast
9.2.3 China 2018-2025 West Nile Virus Infections Medicine Consumption Forecast
9.2.4 Japan 2018-2025 West Nile Virus Infections Medicine Consumption Forecast
9.2.5 Southeast Asia 2018-2025 West Nile Virus Infections Medicine Consumption Forecast
9.2.6 India 2018-2025 West Nile Virus Infections Medicine Consumption Forecast
9.3 West Nile Virus Infections Medicine Market Trend (Product Type)
9.4 West Nile Virus Infections Medicine Market Trend (Application)
10 West Nile Virus Infections Medicine Marketing Type Analysis
10.1 West Nile Virus Infections Medicine Regional Marketing Type Analysis
10.2 West Nile Virus Infections Medicine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of West Nile Virus Infections Medicine by Region
10.4 West Nile Virus Infections Medicine Supply Chain Analysis
11 Consumers Analysis of West Nile Virus Infections Medicine
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global West Nile Virus Infections Medicine Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of West Nile Virus Infections Medicine
Table Product Specifications of West Nile Virus Infections Medicine
Table Classification of West Nile Virus Infections Medicine
Figure Global Production Market Share of West Nile Virus Infections Medicine by Type in
Figure AGS-v Picture
Table Major Manufacturers of AGS-v
Figure BG-323 Picture
Table Major Manufacturers of BG-323
Figure CEL-1000 Picture
Table Major Manufacturers of CEL-1000
Figure FDX-000 Picture
Table Major Manufacturers of FDX-000
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of West Nile Virus Infections Medicine
Figure Global Consumption Volume Market Share of West Nile Virus Infections Medicine by Application in
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of West Nile Virus Infections Medicine by Regions
Figure North America West Nile Virus Infections Medicine Market Size (Million USD) (2013-2025)
Figure Europe West Nile Virus Infections Medicine Market Size (Million USD) (2013-2025)
Figure China West Nile Virus Infections Medicine Market Size (Million USD) (2013-2025)
Figure Japan West Nile Virus Infections Medicine Market Size (Million USD) (2013-2025)
Figure Southeast Asia West Nile Virus Infections Medicine Market Size (Million USD) (2013-2025)
Figure India West Nile Virus Infections Medicine Market Size (Million USD) (2013-2025)
Table West Nile Virus Infections Medicine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of West Nile Virus Infections Medicine in
Figure Manufacturing Process Analysis of West Nile Virus Infections Medicine
Figure Industry Chain Structure of West Nile Virus Infections Medicine
Table Capacity and Commercial Production Date of Global West Nile Virus Infections Medicine Major Manufacturers
Table Manufacturing Plants Distribution of Global West Nile Virus Infections Medicine Major Manufacturers
Table R&D Status and Technology Source of Global West Nile Virus Infections Medicine Major Manufacturers
Table Raw Materials Sources Analysis of Global West Nile Virus Infections Medicine Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of West Nile Virus Infections Medicine E
Figure Global E West Nile Virus Infections Medicine Market Size (Volume) and Growth Rate
Figure Global E West Nile Virus Infections Medicine Market Size (Value) and Growth Rate
Table E Global West Nile Virus Infections Medicine Capacity and Growth Rate
Table Global West Nile Virus Infections Medicine Capacity (K Pcs) List (Company Segment)
Table E Global West Nile Virus Infections Medicine Sales (K Pcs) and Growth Rate
Table Global West Nile Virus Infections Medicine Sales (K Pcs) List (Company Segment)
Table E Global West Nile Virus Infections Medicine Sales Price (USD/Pcs)
Table Global West Nile Virus Infections Medicine Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of West Nile Virus Infections Medicine E
Figure North America E West Nile Virus Infections Medicine Sales Price (USD/Pcs)
Figure North America West Nile Virus Infections Medicine Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of West Nile Virus Infections Medicine E
Figure Europe E West Nile Virus Infections Medicine Sales Price (USD/Pcs)
Figure Europe West Nile Virus Infections Medicine Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of West Nile Virus Infections Medicine E
Figure China E West Nile Virus Infections Medicine Sales Price (USD/Pcs)
Figure China West Nile Virus Infections Medicine Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of West Nile Virus Infections Medicine E
Figure Japan E West Nile Virus Infections Medicine Sales Price (USD/Pcs)
Figure Japan West Nile Virus Infections Medicine Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of West Nile Virus Infections Medicine E
Figure Southeast Asia E West Nile Virus Infections Medicine Sales Price (USD/Pcs)
Figure Southeast Asia West Nile Virus Infections Medicine Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of West Nile Virus Infections Medicine E
Figure India E West Nile Virus Infections Medicine Sales Price (USD/Pcs)
Figure India West Nile Virus Infections Medicine Sales Market Share
Table Global E West Nile Virus Infections Medicine Sales (K Pcs) by Type
Table Different Types West Nile Virus Infections Medicine Product Interview Price
Table Global E West Nile Virus Infections Medicine Sales (K Pcs) by Application
Table Different Application West Nile Virus Infections Medicine Product Interview Price
Table CEL-SCI Corp Information List
Table Product Overview
Table CEL-SCI Corp West Nile Virus Infections Medicine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure CEL-SCI Corp West Nile Virus Infections Medicine Business Region Distribution
Table Fab'entech SA Information List
Table Product Overview
Table Fab'entech SA West Nile Virus Infections Medicine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Fab'entech SA West Nile Virus Infections Medicine Business Region Distribution
Table Hemispherx Biopharma Inc Information List
Table Product Overview
Table Hemispherx Biopharma Inc West Nile Virus Infections Medicine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Hemispherx Biopharma Inc West Nile Virus Infections Medicine Business Region Distribution
Table Kineta Inc Information List
Table Product Overview
Table Kineta Inc West Nile Virus Infections Medicine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Kineta Inc West Nile Virus Infections Medicine Business Region Distribution
Table Nanotherapeutics Inc Information List
Table Product Overview
Table Nanotherapeutics Inc West Nile Virus Infections Medicine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Nanotherapeutics Inc West Nile Virus Infections Medicine Business Region Distribution
Table Plex Pharmaceuticals Inc Information List
Table Product Overview
Table Plex Pharmaceuticals Inc West Nile Virus Infections Medicine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Plex Pharmaceuticals Inc West Nile Virus Infections Medicine Business Region Distribution
Table Theravectys SA Information List
Table Product Overview
Table Theravectys SA West Nile Virus Infections Medicine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Theravectys SA West Nile Virus Infections Medicine Business Region Distribution
Figure Global 2018-2025 West Nile Virus Infections Medicine Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2018-2025 West Nile Virus Infections Medicine Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 West Nile Virus Infections Medicine Sales Price (USD/Pcs) Forecast
Figure North America 2018-2025 West Nile Virus Infections Medicine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2018-2025 West Nile Virus Infections Medicine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2018-2025 West Nile Virus Infections Medicine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 West Nile Virus Infections Medicine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2018-2025 West Nile Virus Infections Medicine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2018-2025 West Nile Virus Infections Medicine Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of West Nile Virus Infections Medicine by Type 2018-2025
Table Global Consumption Volume (K Pcs) of West Nile Virus Infections Medicine by Application 2018-2025
Table Traders or Distributors with Contact Information of West Nile Virus Infections Medicine by Region
Segments Analysis
By Product Type
-
AGS-v
-
BG-323
-
CEL-1000
-
FDX-000
-
Others
By Drug Class (Expanded Segmentation)
-
Antiviral Agents
-
Immunomodulators
-
Monoclonal Antibodies
-
Interferon-Based Therapies
-
Supportive & Adjunctive Therapies
By Route of Administration (New)
-
Intravenous
-
Oral
-
Parenteral
By Application
-
Hospital
-
Clinic
-
Others
By Patient Type (Added)
-
Pediatric
-
Adult
-
Geriatric
Key Market Players
Core Manufacturers
-
CEL-SCI Corp
-
Fab’entech SA
-
Hemispherx Biopharma Inc
-
Kineta Inc
-
Nanotherapeutics Inc
-
Plex Pharmaceuticals Inc
-
Theravectys SA
Additional & Emerging Players (Expanded)
-
Vaxart Inc
-
GeoVax Labs
-
Emergent BioSolutions
-
Bavarian Nordic
-
Avidity Biosciences
